Lv51
1230 积分 2023-12-13 加入
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2小时前
已完结
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
5天前
已完结
Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey
14天前
已完结
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial
15天前
已完结
Chronic Myeloid Leukemia A Review
25天前
已完结
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
28天前
已完结
Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
1个月前
已完结
Medications for Obesity
1个月前
已完结
The evolution of the understanding of obesity over the last 100 years
1个月前
已完结
Immune checkpoints and cancer development: Therapeutic implications and future directions
1个月前
已完结
皖公网安备34019202002308
